This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Claudia S. Costa da Cunha, MD; Céleste Lebbé, MD, PhD; Michel Rybojad, MD; Félix Agbalika, MD; Françoise Ferchal, MD; Claire Rabian, MD; Marie D. Vignon-Pennamen, MD; Fabien Calvo, MD, PhD; Patrice Morel, MD

Arch Dermatol. 1996;132(3):285-290.

Abstract
Background and Design
We reviewed the follow-up of 16 patients with Kaposi's sarcoma not related to human immunodeficiency virus (13 with classic Kaposi's sarcoma and three with endemic Kaposi's sarcoma; median age, 58 years) treated by low-dose recombinant interferon alfa-2b (5 million U three times weekly for at least 6 months).

Results
One patient had a complete response, nine had a major response, three had stable disease, and one had a minor response. Visceral disease stabilized and symptoms improved in three patients. Limited relapse was noted in four patients after withdrawal of interferon.

Conclusion
Our results confirm the efficacy and safety of low-dose recombinant interferon alfa-2b in the longterm treatment of both cutaneous and visceral lesions of Kaposi's sarcoma not related to human immunodeficiency virus.

(Arch Dermatol. 1996;132:285-290)

Author Affiliations
From the Departments of Dermatology (Drs Costa da Cunha, Lebbé, Rybojad, and Morel), Virology (Drs Agbalika and Ferchal), Immunology (Dr Rabian), and Histology (Dr Vignon-Pennamen) and Laboratory of Pharmacology (Dr Calvo), Hôpital Saint Louis, Paris, France.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Classic Kaposi's Sarcoma Associated with Human Herpesvirus 8 Infection in a 13-Year-Old Male: A Case Report
Landau et al.
Clin. Cancer Res. 2001;7:2263-2268.
ABSTRACT | FULL TEXT  

Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells
Monini et al.
J. Virol. 1999;73:4029-4041.
ABSTRACT | FULL TEXT  

Recombinant Interleukin 2 Monotherapy for Classic Kaposi Sarcoma
Shibagaki et al.
Arch Dermatol 1998;134:1193-1196.
FULL TEXT  

Kaposi Sarcoma Unrelated to Human Immunodeficiency Virus Infection: Long-term Results of Radiotherapy
Gonzalez-Acosta et al.
Arch Dermatol 1997;133:107-108.
ABSTRACT  

Treatment of Kaposi's Sarcoma
Tur et al.
Arch Dermatol 1996;132:327-331.
ABSTRACT